Reports and documents

Reports and documents

Investor presentation – BioMed Event – March 8, 2022

Half-year financial report 2021 – October 7, 2021
2020 Annual Financial Report – April 28, 2021
Information document – IPO on Euronext Paris – January 26, 2021
Investor presentation – IPO on Euronext Paris – January 26, 2021

Financial analyses

Invest Securities – Revolutionizing Drug Delivery (Purchase – Target € 12.2) – May 7, 2021